High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma
NCT00165581 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2007-12-21
Summary
The purpose of this study is to understand the side effects (skin reaction, infection and abscess formation) at the site of radiation treatment, which my occur during the treatment and following 2 months using a new method of radiation therapy for breast cancer.
Conditions
Interventions
- DEVICE
-
High Dose Intracavitary Brachytherapy
Sponsors & Collaborators
-
Brigham and Women's Hospital
collaborator OTHER - lead OTHER
Principal Investigators
-
Phillip M. Devlin, MD · Brigham and Women's Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2006-10-31
- Completion
- 2006-10-31
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy in Treating Women With Early Stage Breast Cancer
NCT00909909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
NCT01349322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer
NCT01175694 ·Status: UNKNOWN ·Phase: PHASE2
-
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
NCT04052555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
NCT00872625 ·Status: COMPLETED ·Phase: PHASE1
-
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
NCT02364557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
NCT00063102 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NCT07021846 ·Status: RECRUITING ·Phase: NA
-
Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
NCT00001440 ·Status: COMPLETED ·Phase: PHASE1
-
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
NCT03624478 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
NCT00003857 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast
NCT00470236 ·Status: UNKNOWN ·Phase: NA
-
Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer
NCT01948726 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
NCT00077168 ·Status: UNKNOWN ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
NCT06260033 ·Status: RECRUITING ·Phase: PHASE2
-
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer
NCT01928589 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Partial Breast Irradiation With Chemotherapy
NCT00278109 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery
NCT02658812 ·Status: TERMINATED ·Phase: PHASE2
-
Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer
NCT00206453 ·Status: TERMINATED ·Phase: PHASE2
-
Proton Radiation for Stage II/III Breast Cancer
NCT01758445 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I Symporter
NCT02988648 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
NCT06018337 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Stereotactic Radiotherapy for Breast Cancer
NCT03043794 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens
NCT00681993 ·Status: COMPLETED ·Phase: NA
-
Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
NCT01232062 ·Status: COMPLETED